在缺血性中风中,MT1受体作为ramelteon神经保护的目标
Xinmu Zhang1,2, Bin Peng1,3, Shenqi Zhang4
1Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Journal of pineal research
|November 21, 2023
概括
拉梅尔顿是一种黑激素受体1A (MT1) 激动剂,表现出对缺血性中风的神经保护作用. MT1受体激活是中风治疗的一个有前途的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物医学研究生物医学研究
背景情况:
- 卒中仍然是全球死亡率和长期残疾的主要原因.
- 对于缺血性中风的创新和有效的治疗策略有着至关重要的需求.
- 黑色素受体1A (MT1) 信号与各种生理过程有关,但其在缺血性中风中的作用尚未完全理解.
研究的目的:
- 在缺血性中风的实验模型中研究Ramelteon的神经保护潜力,一个MT1激动剂.
- 阐明拉梅尔顿神经保护作用的潜在机制,重点关注MT1受体参与.
- 确定MT1作为潜在的中风干预治疗点.
主要方法:
- 使用了综合的体内 (中脑动脉封闭小鼠模型),体外 (有机型海马片培养) 和体外 (培养的神经元) 缺血性中风模型.
- 采用MT1-Knockout (KO) 鼠和神经元来评估MT1受体的特定作用.
- 进行生物信息分析 (Connectivity Map L1000) 和分子测试,以探索参与神经保护的信号通路.
主要成果:
- 在所有实验模型中,Ramelteon显示出显著的神经保护作用,在MT1-KO受试者中有效性降低.
- 在MCAO小鼠大脑中,MT1受体表达被发现被耗尽,ramelteon治疗恢复了这些水平.
- 拉梅尔改善了大脑的血液流动,抵消了氧化应激,激活了Nrf2 / Heme氧化酶-1通路,并抑制了线粒体和自细胞死亡通路.
结论:
- 拉梅尔顿是一种有希望的神经保护药物候选人,用于缺血性中风.
- MT1受体被确定为中风治疗的关键神经保护点.
- MT1-KO模型为研究加速性缺血损伤和神经元细胞死亡提供了宝贵的工具.
相关概念视频
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...